ADVANCED COLORECTAL CARCINOMA
Clinical trials for ADVANCED COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on Hard-to-Treat cancers shows early promise
Disease control OngoingThis early-phase trial tests a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (which blocks a DNA repair enzyme)—in people with advanced solid tumors that have a HER2 mutation. The goal is to find the safest dose and see if the combo wo…
Matched conditions: ADVANCED COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New hope for Tough-to-Treat colorectal cancer: drug combo under study
Disease control TerminatedThis study is for people with advanced colorectal cancer that has a specific genetic change called a KRAS mutation and has stopped responding to standard treatments. Researchers are testing the safety and effectiveness of combining two drugs, AVUTOMETINIB and cetuximab. The goal …
Matched conditions: ADVANCED COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 26, 2026 04:57 UTC